arrow
W

Wolfgang G. Kunz

Helmholtz Association
H指数:32
被引数:4,967

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CT-Derived Muscle and Adipose Tissue Characteristics and Survival in Advanced NSCLC Treated with First-Line Immunotherapy-Based Regimens

基于CT的肌肉和脂肪组织特征与接受一线免疫疗法方案治疗的晚期NSCLC患者的生存期

Cancers
IF4.4
2026-09-040
OA
Variations in surgical strategies and treatment allocation for retroperitoneal sarcomas across German-speaking sarcoma centres

德语区肉瘤中心在腹膜后肉瘤的手术策略和治疗分配方面的差异

EJSO
IF2.9
2026-08-010
PRE
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

更正:EORTC和ESGAR关于局部和局部区域治疗中肝细胞癌分期、治疗计划制定和监测的影像学应用:共识建议

2025-10-310
OA
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma

CD19 CAR-T在大型B细胞淋巴瘤中国际代谢预后指数的优化与验证

2025-08-260
OAAI
Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation

[¹⁸F]SiTATE PET/CT中SUV阈值在准确脑膜瘤分割中的验证

2025-07-230
OAAI
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

在局部和局部区域治疗中,肝细胞癌分期、治疗计划和监测的影像学应用:EORTC和ESGAR的共识建议

2025-05-230
OA
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma

纳武利尤单抗联合局部热疗在PD-L1阴性转移性头颈鳞状细胞癌患者中诱导了持久的应答

2025-04-170
OA
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
2025-03-170
OAAI